Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab. acbr [Internet]. 2021 Dec. 10 [cited 2026 Sep. 17];5(6):972-8. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/14882